Silverback Therapeutics Inc (SBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBTX | NVCT | CDXS | ||
| Company | Silverback Therapeutics Inc | Nuvectis Pharma Inc | Codexis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.82 | 8.22 | 2.24 | ||
| High | 6.15 | 8.53 | 2.34 | ||
| Low | 5.72 | 8.13 | 2.23 | ||
| Latest | 5.87 | 8.46 | 2.30 | ||
| Change | +0.06 | +0.24 | +0.06 | ||
| % Change | +1.03% | +2.92% | +2.68% | ||
| Volume | 116,700 | 34,300 | 926,100 | ||
| 20-Day Average Volume | 195,280 | 61,585 | 1,661,710 | ||
| Previous Close | 5.81 | 8.22 | 2.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.79 | 8.03 | 1.79 | ||
| 20-Day Raw Stochastic | 60.38% | 60.71% | 84.76% | ||
| 20-Day Relative Strength | 54.62 | 53.22 | 68.04 | ||
| Weighted Alpha | -17.00 | +4.50 | +21.12 | ||
| Today's Opinion | 100% Buy | 56% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 24% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.55% since 11/01/22 | +10.59% since 04/06/26 | +21.69% since 04/06/26 | ||
| Low | 5.72 on 11/08/22 | 7.57 on 04/07/26 | 1.81 on 04/07/26 | ||
| High | 6.46 on 11/02/22 | 8.53 on 04/13/26 | 2.46 on 04/10/26 | ||
| 1-Month | |||||
| %Chg | +11.81% since 10/07/22 | -6.31% since 03/13/26 | +42.86% since 03/13/26 | ||
| Low | 4.91 on 10/13/22 | 7.17 on 03/30/26 | 1.41 on 03/18/26 | ||
| High | 6.50 on 10/31/22 | 9.30 on 03/16/26 | 2.46 on 04/10/26 | ||
| 3-Month | |||||
| %Chg | +17.87% since 08/08/22 | +1.81% since 01/13/26 | +34.50% since 01/13/26 | ||
| Low | 4.45 on 09/23/22 | 7.17 on 03/30/26 | 0.96 on 03/04/26 | ||
| High | 6.50 on 10/31/22 | 9.88 on 03/10/26 | 2.46 on 04/10/26 | ||
| 6-Month | |||||
| %Chg | +94.37% since 05/06/22 | +36.67% since 10/13/25 | -8.00% since 10/13/25 | ||
| Low | 2.80 on 05/12/22 | 5.55 on 11/07/25 | 0.96 on 03/04/26 | ||
| High | 6.50 on 10/31/22 | 9.88 on 03/10/26 | 2.82 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 211,660 | 217,764 | 203,547 | ||
| Shares Outstanding, K | 36,058 | 26,492 | 90,869 | ||
| Annual Sales | 0 | 0 | 70,390,000 | ||
| Annual Net Income | -89,480,000 | -26,440,000 | -43,970,000 | ||
| Last Quarter Sales | 0 | 0 | 38,920,000 | ||
| Last Quarter Net Income | -17,860,000 | -7,310,000 | 9,600,000 | ||
| 60-Month Beta | 0.60 | -0.21 | 2.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 11/02/22 | -0.31 on 02/11/26 | 0.11 on 03/11/26 | ||
| Latest Earnings Date | 03/30/23 | 05/05/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||